Ocugen Inc (OCGN)
0.9509
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.96
+0.01
(+0.96%)
After-Hours: 20:00
Ocugen Enterprise Value: 260.88M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 260.88M |
| November 01, 2024 | 260.42M |
| October 31, 2024 | 249.40M |
| October 30, 2024 | 267.53M |
| October 29, 2024 | 264.45M |
| October 28, 2024 | 277.90M |
| October 25, 2024 | 253.31M |
| October 24, 2024 | 244.33M |
| October 23, 2024 | 249.14M |
| October 22, 2024 | 254.87M |
| October 21, 2024 | 257.29M |
| October 18, 2024 | 257.75M |
| October 17, 2024 | 254.90M |
| October 16, 2024 | 257.49M |
| October 15, 2024 | 259.79M |
| October 14, 2024 | 260.60M |
| October 11, 2024 | 270.70M |
| October 10, 2024 | 260.19M |
| October 09, 2024 | 260.31M |
| October 08, 2024 | 262.99M |
| October 07, 2024 | 272.83M |
| October 04, 2024 | 277.90M |
| October 03, 2024 | 259.91M |
| October 02, 2024 | 266.38M |
| October 01, 2024 | 260.63M |
| Date | Value |
|---|---|
| September 30, 2024 | 272.77M |
| September 27, 2024 | 280.78M |
| September 26, 2024 | 270.82M |
| September 25, 2024 | 282.22M |
| September 24, 2024 | 268.17M |
| September 23, 2024 | 286.53M |
| September 20, 2024 | 306.68M |
| September 19, 2024 | 315.32M |
| September 18, 2024 | 309.56M |
| September 17, 2024 | 309.56M |
| September 16, 2024 | 323.95M |
| September 13, 2024 | 335.47M |
| September 12, 2024 | 332.59M |
| September 11, 2024 | 341.23M |
| September 10, 2024 | 344.10M |
| September 09, 2024 | 346.98M |
| September 06, 2024 | 315.32M |
| September 05, 2024 | 326.83M |
| September 04, 2024 | 321.08M |
| September 03, 2024 | 335.47M |
| August 30, 2024 | 361.38M |
| August 29, 2024 | 352.74M |
| August 28, 2024 | 358.50M |
| August 27, 2024 | 370.01M |
| August 26, 2024 | 378.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.722M
Minimum
Nov 22 2019
3.066B
Maximum
May 03 2021
438.04M
Average
251.70M
Median
Oct 19 2022
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.655B |
| Scholar Rock Holding Corp | 2.074B |
| Mirum Pharmaceuticals Inc | 1.958B |
| SpringWorks Therapeutics Inc | 1.913B |
| NeuroBo Pharmaceuticals Inc | -6.462M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.28M |
| Revenue (Quarterly) | 1.141M |
| Total Expenses (Quarterly) | 16.59M |
| EPS Diluted (Quarterly) | -0.04 |
| Profit Margin (Quarterly) | -1.34K% |
| Earnings Yield | -19.98% |
| Normalized Earnings Yield | -19.98 |